secwatch.observer — SEC 8-K summary
======================================

Issuer:     LISATA THERAPEUTICS, INC. (LSTA)
CIK:        0000320017
Form:       8-K
Filed at:   2026-06-01T10:03:38+00:00
Accession:  0001140361-26-023397
Event type: m_and_a
Sentiment:  negative
Materiality: 0.85
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Kuva Labs notifies Lisata it will not commence tender offer on June 1 as agreed; deal uncertain
--------------------------------------------------------------------------------

- On May 31, Kuva Labs told Lisata it will not start the tender offer on June 1 as previously agreed and amended.
- No assurance on when or if the tender offer will commence; Kuva is still negotiating financing sources.
- Merger Agreement signed March 6, 2026; amendment on May 29 extended start date to June 1.
- Parent's failure to commence as agreed raises concern about deal completion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/320017/000114036126023397/0001140361-26-023397-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/320017/000114036126023397/ef20075280_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-023397

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer